Technical Analysis for CANF - Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Grade Last Price % Change Price Change
D 2.08 5.58% 0.11
CANF closed up 5.58 percent on Friday, May 14, 2021, on 3 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical CANF trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 200 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Resistance Bearish 5.58%
Outside Day Range Expansion 5.58%
Oversold Stochastic Weakness 5.58%
200 DMA Resistance Bearish 4.00%
Lower Bollinger Band Walk Weakness 4.00%
Oversold Stochastic Weakness 4.00%
Older End-of-Day Signals for CANF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Can-Fite BioPharma, Ltd., a biotechnology company, develops drugs for the treatment of cancer and autoimmune inflammatory diseases. The company principally develops CF101 that is in Phase III study for the treatment of psoriasis; and has completed Phase II study for the treatment of rheumatoid arthritis and glaucoma, as well as completed Phase III study for the treatment of dry eye and Phase I study for the treatment of uveitis. It also develops CF102, which is in Phase II study for the treatment of hepatocellular carcinoma; and CF602 that has completed pre-clinical trial for the treatment of inflammatory diseases. The company was founded in 2000 and is based in Petach Tikva, Israel.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Immunology Treatment Of Cancer Inflammatory Disease Inflammatory Diseases Rheumatoid Arthritis Carcinoma Psoriasis Glaucoma Arthritis Hepatocellular Carcinoma Immunosuppressants Petach Uveitis Biotie Therapies Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases Treatment Of Psoriasis Immune Inflammatory Diseases

Is CANF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.38
52 Week Low 1.51
Average Volume 4,096,978
200-Day Moving Average 2.04
50-Day Moving Average 2.24
20-Day Moving Average 2.12
10-Day Moving Average 2.05
Average True Range 0.12
ADX 14.8
+DI 18.70
-DI 17.61
Chandelier Exit (Long, 3 ATRs ) 1.96
Chandelier Exit (Short, 3 ATRs ) 2.30
Upper Bollinger Band 2.31
Lower Bollinger Band 1.93
Percent B (%b) 0.39
BandWidth 17.92
MACD Line -0.07
MACD Signal Line -0.06
MACD Histogram -0.0072
Fundamentals Value
Market Cap 32.06 Million
Num Shares 15.4 Million
EPS -5.01
Price-to-Earnings (P/E) Ratio -0.42
Price-to-Sales 21.45
Price-to-Book 3.07
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.25
Resistance 3 (R3) 2.23 2.15 2.22
Resistance 2 (R2) 2.15 2.11 2.16 2.21
Resistance 1 (R1) 2.12 2.09 2.14 2.14 2.20
Pivot Point 2.04 2.04 2.05 2.05 2.04
Support 1 (S1) 2.01 2.00 2.03 2.03 1.96
Support 2 (S2) 1.93 1.98 1.94 1.95
Support 3 (S3) 1.90 1.93 1.94
Support 4 (S4) 1.92